Allergan reaction: Teva meets banks for $34bn M&A financing
Teva, the Israeli pharmaceutical company, will hold a meeting with banks on Wednesday for the syndication of $33.75bn of loans it is using to buy generic drug business Allergan Generics.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: